 This clinical trial is a single centre phase Ib open dose adjustment study with respect to the dose of C-Tb combined with a double blind randomised, split-body comparison of unpreserved C-Tb and C-Tb preserved with 0.5 phenol each patient receives the unpreserved version in one arm and the preserved version in the other arm. 